Mid-Atlantic BioTherapeutics
Mid-Atlantic BioTherapeutics they are focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. They are actively addressing the growing antibiotic resistance problems and creating a revolutionary treatment paradigm for viral diseases (e.g., the Tamiflu alternative for influenza), emerging infectious diseases, and biodefense.
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Mid-Atlantic BioTherapeutics use?+
Mid-Atlantic BioTherapeutics uses 12 technologies including PHP, WordPress, FameThemes OnePress.
What industry is Mid-Atlantic BioTherapeutics in?+
Mid-Atlantic BioTherapeutics operates in the Life Science industry.
Where is Mid-Atlantic BioTherapeutics based?+
Mid-Atlantic BioTherapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026